🇺🇸 Syntocinon in United States

465 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Exposure During Pregnancy — 110 reports (23.66%)
  2. Caesarean Section — 73 reports (15.7%)
  3. Postpartum Haemorrhage — 52 reports (11.18%)
  4. Hypotension — 48 reports (10.32%)
  5. Maternal Exposure During Pregnancy — 44 reports (9.46%)
  6. Drug Ineffective — 35 reports (7.53%)
  7. Exposure During Pregnancy — 32 reports (6.88%)
  8. Foetal Distress Syndrome — 26 reports (5.59%)
  9. Dyspnoea — 23 reports (4.95%)
  10. Bradycardia — 22 reports (4.73%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Syntocinon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Syntocinon in United States?

Shana McCormack, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.